Nautilus Biotechnology, Inc. (NAUT)
2.08
+0.04
(+1.96%)
USD |
NASDAQ |
Dec 10, 11:49
Nautilus Biotechnology Market Cap: 262.71M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Prelude Therapeutics, Inc. | 104.36M |
| Protalix Biotherapeutics, Inc. | 142.35M |
| Genprex, Inc. | 3.314M |
| GoodRx Holdings, Inc. | 940.23M |
| Pelthos Therapeutics, Inc. | 17.11M |
Market Cap Related Metrics
| Price to Book Value | 1.553 |
| Price | 2.08 |
| Earnings Yield | -23.95% |